UPDATED Apr 20, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
WM | US$207.07 | 0.8% | 25.4% | US$83.2b | US$212.95 | PE36.1x | E10.9% | 1.4% | ||
CTAS | US$661.29 | -1.1% | 43.8% | US$67.1b | US$687.35 | PE44.8x | E8.5% | 0.8% | ||
RSG | US$189.76 | 1.0% | 36.9% | US$59.8b | US$199.89 | PE34.5x | E7.6% | 1.1% | ||
CPRT | US$52.88 | -4.5% | 34.9% | US$50.8b | US$54.93 | PE37.5x | E9.4% | n/a | ||
WCN | US$165.02 | -1.3% | 13.7% | US$42.6b | US$180.33 | PE55.8x | E16.9% | 0.7% | ||
VLTO | US$88.89 | 1.7% | n/a | US$21.9b | US$95.80 | PE26.2x | E4.3% | 0.4% | ||
ROL | US$42.51 | -4.1% | 7.3% | US$20.6b | US$44.76 | PE47.4x | E10.6% | 1.4% | ||
BXB | AU$15.53 | -1.5% | 10.0% | AU$21.6b | AU$16.13 | PE19.7x | E8.0% | 3.0% | ||
RBA | US$72.61 | -0.6% | 23.7% | US$13.3b | US$78.45 | PE75.9x | E23.7% | 1.5% | ||
RTO | UK£4.23 | -6.7% | -31.3% | UK£10.6b | UK£5.53 | PE27.9x | E16.8% | 2.1% | ||
GFL | CA$45.56 | -1.0% | -3.7% | CA$17.2b | CA$52.59 | PE377.8x | E54.9% | 0.2% | ||
CLH | US$193.71 | -1.6% | 34.6% | US$10.4b | US$213.88 | PE27.7x | E12.1% | n/a | ||
TTEK | US$184.67 | -3.8% | 29.7% | US$9.9b | US$200.40 | PE42.6x | E25.5% | 0.6% | ||
MSA | US$185.38 | -2.6% | 41.6% | US$7.3b | US$191.00 | PE124.6x | E58.0% | 1.0% | ||
EFN | CA$21.50 | -0.2% | 25.4% | CA$8.4b | CA$27.33 | PE18.9x | E12.3% | 2.2% | ||
CWST | US$93.43 | -1.9% | 5.0% | US$5.4b | US$104.43 | PE213.3x | E36.5% | n/a | ||
SRCL | US$49.91 | 1.3% | 18.6% | US$4.6b | US$64.60 | PS1.7x | E38.2% | n/a | ||
BYD | CA$269.64 | -2.1% | 25.7% | CA$5.8b | CA$327.22 | PE48.6x | E26.8% | 0.2% | ||
BCO | US$87.04 | 0.08% | 33.6% | US$3.9b | US$106.50 | PE45.3x | S5.3% | 1.0% | ||
CWY | AU$2.54 | -2.3% | 2.8% | AU$5.7b | AU$2.80 | PE120.7x | E27.5% | 1.9% | ||
UNF | US$158.51 | -1.8% | -7.2% | US$3.0b | US$180.25 | PE25.8x | E13.3% | 0.8% | ||
ACVA | US$17.31 | -2.2% | 46.6% | US$2.9b | US$21.33 | PS5.9x | E51.8% | n/a | ||
BRC | US$58.65 | -0.4% | 11.8% | US$2.8b | US$68.50 | PE15.1x | E5.2% | 1.6% | ||
ABM | US$44.32 | 1.7% | 4.8% | US$2.8b | US$50.83 | PE10.9x | E-7.2% | 2.0% |